COLUMBUS, Ohio – Dr. Carlo Croce
, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, received the 2012 Anthony Dipple Carcinogenesis Award
The award, sponsored by Oxford University Press, is given to individuals who have added major contributions to research in how cancer develops, the field of study called carcinogenesis. The award will be presented at the 2012 biennial meeting of the European Association for Cancer Research (EACR) in Barcelona, Spain on July 7-10.
Croce, also the John W. Wolfe Chair in Human Cancer Genetics, recently received one of the nation’s highest honors with his induction as a member of the Institute of Medicine
of the National Academies.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute
(NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.
Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu